ES-SCLCsmall cell lung cancertarlatamabatezolizumabdurvalumabMerck Sharp & Dohme LLCcarboplatin
…ons This study showed that while more than 70% of patients with ES-SCLC received ICI-containing regimens as first-line treatment, progn…
7articles mentioning diseases
25disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: ES-SCLC ×
ES-SCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning ES-SCLC
7 articles · page 1 of 1ES-SCLCextensive-stage small-cell lung cancerTislelizumabdurvalumabatezolizumab
…d consistent placebo outcomes, they may be considered CETAs for ES-SCLC first-line treatment, despite potential OS bias from subsequent…
ES-SCLCextensive-stage small-cell lung cancersolid tumoursatezolizumabtertiary hospitalanticancer immunotherapy
…izumab infusions (early vs late) is associated with efficacy in ES-SCLC. The primary outcome was overall survival (OS). Secondary outco…
ES-SCLCatezolizumab
…lizumab, led to long-term survival in a subset of patients with ES-SCLC. This outcome was associated with expansion after treatment of …
extensive-stage small cell lung cancerextensive-stage small-cell lung cancerES-SCLCdurvalumabatezolizumabplatinum-etoposidetremelimumabimmunotherapy
…uszko R, Sugawara S, et al. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and…
ES-SCLCextensive-stage small cell lung cancerChemoimmunotherapyCITsingle-agent immunotherapy
…lapse while off therapy. Here, we are presenting a patient with ES-SCLC, who stopped treatment at 2 years, with disease relapse shortly…
metastatic melanomaaNSCLCES-SCLCadvanced non-small cell lung cancerkidney cancerextensive-stage small cell lung cancermelanomaRCCskin cancersmetastatic renal cell carcinoma+1 more
…for all indications (A), metastatic RCC and kidney cancers (B), metastatic melanoma and skin cancers (C), and extensive-stage SCLC (D). Predetermin…